Clark Capital Management Group’s Antares Pharma, Inc. ATRS Stock Holding History

Clark Capital Management Group’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$8.7K	–	370
2016 Q1	$8.7K	Hold	10,000	–	–	﹤0.01%	314
2015 Q4	$12K	Hold	10,000	–	–	﹤0.01%	300
2015 Q3	$17K	Sell	10,000 -2,400	-19%	-$4.7K	﹤0.01%	302
2015 Q2	$26K	Buy	12,400 +2,400	+24%	+$5.82K	﹤0.01%	319
2015 Q1	$27K	Hold	10,000	–	–	﹤0.01%	312
2014 Q4	$26K	Hold	10,000	–	–	﹤0.01%	307
2014 Q3	$18K	Hold	10,000	–	–	﹤0.01%	297
2014 Q2	$27K	Hold	10,000	–	–	﹤0.01%	319
2014 Q1	$35K	Hold	10,000	–	–	﹤0.01%	331
2013 Q4	$45K	Hold	10,000	–	–	﹤0.01%	331
2013 Q3	$41K	Hold	10,000	–	–	﹤0.01%	334
2013 Q2	$42K	Buy	+10,000	New	+$38.6K	﹤0.01%	323

Other funds holding ATRS

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WHI

William Harris Investors Chicago, Illinois $347M AUM 3.53% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PLP

Pleasant Lake Partners Rincon, Puerto Rico $7.91M AUM 5.74% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Clark Capital Management Group's ATRS Position: Q2 2016 in Review

Clark Capital Management Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2016, closing a stake of 10,000 shares — an estimated $8.7K sold.

Clark Capital Management Group first reported a position in ATRS in Q2 2013 and held it in 12 quarters. The position peaked at $45K in Q4 2013. 71 funds tracked by Wall St. Rank hold ATRS as of Q2 2016.

Clark Capital Management Group reported no remaining Antares Pharma, Inc. position as of Q2 2016 after selling out during the quarter.
Clark Capital Management Group sold 10,000 Antares Pharma, Inc. shares in Q2 2016, an estimated $8.7K.
Clark Capital Management Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 12 quarters.
Clark Capital Management Group's Antares Pharma, Inc. position peaked at $45K in Q4 2013.
71 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2016.

Based on Clark Capital Management Group's 13F filing for Q2 2016, filed 15 Aug 2016.